Who owns Enzo Biochem?
- Ticker: ENZ
- CUSIP Number: 294100102
Tip: Access positions for across all investors
Analyze quarterly positions in Enzo Biochem with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Enzo Biochem stock
Who bought or sold Enzo Biochem this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Renaissance Technologies | 2.5M | $2.8M | 1% | Sep 2024 |
|
| Vanguard Group | 1.9M | $2.0M | 0% | Jun 2024 |
|
| BlackRock | 959k | $1.1M | 100% | Sep 2024 |
|
| BlackRock | 955k | $1.0M | 0% | Jun 2024 |
|
| Geode Capital Management | 369k | $413k | 3% | Sep 2024 |
|
| Dimensional Fund Advisors | 305k | $341k | -11% | Sep 2024 |
|
| State Street Corporation | 154k | $168k | 0% | Jun 2024 |
|
| Bridgeway Capital Management | 132k | $144k | -42% | Jun 2024 |
|
| BBR Partners | 100k | $112k | 100% | Sep 2024 |
|
| Nierenberg Investment Management Company | 89k | $97k | 666% | Jun 2024 |
|
| Morgan Stanley | 72k | $78k | 0% | Jun 2024 |
|
| Northern Trust | 67k | $75k | 0% | Sep 2024 |
|
| Lazard Asset Management | 51k | $56k | 0% | Sep 2024 |
|
| T. Rowe Price Associates | 45k | $51k | 0% | Sep 2024 |
|
| Citadel Advisors | 29k | $32k | -15% | Sep 2024 |
|
| Kempner Capital Management | 26k | $29k | 0% | Sep 2024 |
|
| FNY Investment Advisers | 20k | $22k | 100% | Sep 2024 |
|
| Paradigm Financial Partners | 20k | $22k | 0% | Sep 2024 |
|
| Raymond James Trust | 17k | $19k | 0% | Sep 2024 |
|
| Shulman DeMeo Asset Management | 16k | $17k | 0% | Sep 2024 |
|
| Manufacturers Life Insurance Company | 15k | $16k | 100% | Jun 2024 |
|
| TLS Advisors | 14k | $15k | 0% | Sep 2024 |
|
| Charles Schwab Investment Management | 14k | $15k | 0% | Sep 2024 |
|
| Snowden Capital Advisors | 10k | $12k | -15% | Sep 2024 |
|
| Tower Research Capital | 4.3k | $4.6k | -65% | Jun 2024 |
|
| Covestor | 4.0k | $4.0k | 0% | Sep 2024 |
|
| BFSG | 2.8k | $3.2k | 0% | Sep 2024 |
|
| Simplex Trading | 2.8k | $3.0k | 73% | Sep 2024 |
|
| Bank of America Corporation | 2.2k | $2.5k | 0% | Sep 2024 |
|
| Jpmorgan Chase & Co | 1.8k | $2.1k | 0% | Sep 2024 |
|
| Royal Bank of Canada | 1.0k | $1.0k | -7% | Sep 2024 |
|
| Wells Fargo & Company | 578.00 | $647.995800 | 0% | Sep 2024 |
|
| Clear Point Advisors | 120.00 | $134.004000 | 0% | Sep 2024 |
|
| Advisor Group Holdings | 120.00 | $134.004000 | -89% | Sep 2024 |
|
| Bnp Paribas | 79.00 | $87.998100 | 100% | Sep 2024 |
|
| Sound Income Strategies | 10.00 | $11.000000 | 0% | Sep 2024 |
|
Who sold out of Enzo Biochem?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| XTX Topco | Jun 2024 | 28k | $31k |
| Assenagon Asset Management | Jun 2024 | 20k | $22k |
| Millennium Management | Jun 2024 | 19k | $21k |
| PFG Investments | Mar 2024 | 19k | $24k |
| Benjamin Edwards | Jun 2024 | 300.00 | $0 |
| Goss Wealth Management | Mar 2024 | 10.00 | $13.000000 |